Characteristics and prognosis of pelvic Ewing sarcoma: a SEER population-based study
- PMID: 31576245
- PMCID: PMC6753919
- DOI: 10.7717/peerj.7710
Characteristics and prognosis of pelvic Ewing sarcoma: a SEER population-based study
Abstract
Background: The pelvis is one of the primary sites of Ewing sarcoma (ES) and is associated with poorer prognoses than the extremities. Due to the rarity of this disease and limited data available, the prognostic factors of pelvic ES remain controversial. Thus, this study aimed to identify independent prognostic factors, and develop a nomogram for predicting survival rates in patients with pelvic ES.
Methods: Using data provided by the Surveillance, Epidemiology, and End Results (SEER) database, variables including age, sex, race, tumor size, tumor stage, surgery, and radiotherapy were analyzed using the Kaplan-Meier method and Cox proportional hazards regression. Based on the results of multivariate analyses, a nomogram was built to predict the overall survival (OS) of patients with pelvic ES. The performance of the nomogram was evaluated by the concordance index (C-index).
Results: A total of 267 cases diagnosed between 2004 and 2016 were included in the study. Univariate and multivariate analyses showed that patients who were younger, white, had a localized tumor stage, or underwent surgery were associated with improved prognoses, while no significant differences were observed in OS based on sex, tumor size, or radiotherapy. A nomogram was developed and the C-index was 0.728, indicating adequate performance for survival prediction.
Conclusions: Age, race, tumor stage, and surgery were identified as independent prognostic factors for the OS of pelvic ES. The nomogram developed in this study can individually predict 3- and 5-year OS in patients with pelvic ES.
Keywords: Nomogram; Pelvic Ewing sarcoma; Prognosis; SEER.
© 2019 Chen et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Overall survival comparison between pediatric and adult Ewing sarcoma of bone and adult nomogram construction: a large population-based analysis.Front Pediatr. 2023 May 23;11:1103565. doi: 10.3389/fped.2023.1103565. eCollection 2023. Front Pediatr. 2023. PMID: 37287626 Free PMC article.
-
A nomogram to predict prognosis in Ewing sarcoma of bone.J Bone Oncol. 2019 Feb 12;15:100223. doi: 10.1016/j.jbo.2019.100223. eCollection 2019 Apr. J Bone Oncol. 2019. PMID: 30815343 Free PMC article.
-
Identifying the Risk Factors and Estimating the Prognosis in Patients with Pelvis and Spine Ewing Sarcoma: A Population-Based Study.Spine (Phila Pa 1976). 2021 Oct 1;46(19):1315-1325. doi: 10.1097/BRS.0000000000004022. Spine (Phila Pa 1976). 2021. PMID: 34517400
-
Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.BMC Urol. 2021 Nov 25;21(1):162. doi: 10.1186/s12894-021-00929-x. BMC Urol. 2021. PMID: 34823525 Free PMC article.
-
Prognostic nomograms to predict overall survival and cancer-specific survival in patients with pelvic chondrosarcoma.Cancer Med. 2019 Sep;8(12):5438-5449. doi: 10.1002/cam4.2452. Epub 2019 Jul 29. Cancer Med. 2019. PMID: 31353800 Free PMC article.
Cited by
-
A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study.BMC Cancer. 2022 Aug 23;22(1):914. doi: 10.1186/s12885-022-09796-7. BMC Cancer. 2022. PMID: 35999524 Free PMC article.
-
Lung Metastasis Probability in Ewing Sarcoma: A Nomogram Based on the SEER Database.Curr Oncol. 2020 Dec 5;28(1):69-77. doi: 10.3390/curroncol28010009. Curr Oncol. 2020. PMID: 33704176 Free PMC article.
-
Clinical Features, Risk Factors, and Prediction Nomogram for Primary Spinal Osteosarcoma: A Large-Cohort Retrospective Study.Global Spine J. 2024 Apr;14(3):930-940. doi: 10.1177/21925682221129219. Epub 2022 Sep 25. Global Spine J. 2024. PMID: 36154721 Free PMC article.
-
Dextrose Prolotherapy to Treat Pain, Improve Activities of Daily Living, and Improve Quality of Life in an Ewing's Sarcoma Patient Following Radiation and Chemotherapy Treatment.Cureus. 2021 Feb 25;13(2):e13549. doi: 10.7759/cureus.13549. Cureus. 2021. PMID: 33791172 Free PMC article.
-
Bilateral primary ovarian Ewing sarcoma recurring as left submandibular lymphadenopathy diagnosed on cytology.Autops Case Rep. 2024 Jul 12;14:e2024499. doi: 10.4322/acr.2024.499. eCollection 2024. Autops Case Rep. 2024. PMID: 39021466 Free PMC article.
References
-
- Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA. Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems. Journal of Clinical Oncology. 2016;34(36):4415–4420. doi: 10.1200/JCO.2016.68.9372. - DOI - PMC - PubMed
-
- Albergo JI, Gaston CLL, Parry MC, Laitinen MK, Jeys LM, Tillman RM, Abudu AT, Grimer RJ. Risk analysis factors for local recurrence in Ewing’s sarcoma: when should adjuvant radiotherapy be administered? Bone & Joint Journal. 2018;100-B(2):247–255. doi: 10.1302/0301-620X.100B2.BJJ-2017-0222.R1. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources